← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 1998Last known activity
Mar 1, 2015
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Arteritis
- Bronchitis
- Bronchitis, Chronic
- Chronic Disease
- Collagen Diseases
- Colorectal Neoplasms
- Giant Cell Arteritis
- Granulomatosis with Polyangiitis
- Lung Diseases
- Lung Diseases, Obstructive
- Neoplasms
- Osteoporosis
- Peritoneal Neoplasms
- Polymyalgia Rheumatica
- Polymyositis
- Pulmonary Disease, Chronic Obstructive
- Rheumatic Diseases
Recent trials (4)
- NCT02231086CollaboratorPhase 3Mar 1, 2015
- NCT00189098CollaboratorN/AFeb 1, 2003
- NCT00138983CollaboratorPhase 3May 1, 2000
- NCT00184977CollaboratorPhase 4Dec 1, 1998
Details
- Last known activity
- Mar 1, 2015